首页 > 产品中心 > 有机化学 > 一般有机化学品

(1-((2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-2-丁基-5-氯-1H-咪唑-4-基)甲醇

Imp. C (EP): [2-Butyl-5-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-4-yl]methanol

产品编号.: A799132 CAS号: 114799-13-2
分子式: C22H23N6OCl 分子量: 422.91062
纯度: 98% MDL NO.:

中文名称：(1-((2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-2-丁基-5-氯-1H-咪唑-4-基)甲醇
CAS号：114799-13-2
中文别名：洛沙坦钾杂质C;(3-甲基丙烯酰胺丙基)三乙氧基硅烷;氯沙坦杂质C;洛沙坦杂质C;洛沙坦杂质C 标准品;氯沙坦钾EP杂质C;氯沙坦杂质 C;氯沙坦杂质 C
英文名称：Imp. C (EP): [2-Butyl-5-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-4-yl]methanol
英文别名：Imp. C (EP): [2-Butyl-5-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-4-yl]methanol;[2-butyl-5-chloro-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-4-methanol;Losartan IMpurity C (Isolosartan);Losartan EP Impurity C (Isolosartan);(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;[2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol;SCHEMBL3121770;SCHEMBL3121770;Losartan Potassium Imp. C (EP); Losartan Imp. C (EP); [2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol; Losartan Potassium Impurity C; Losartan Impurity C;Losartan Potassium Imp. C (EP); Losartan Imp. C (EP); [2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol; Losartan Potassium Impurity C; Losartan Impurity C;1H-Imidazole-4-methanol, 2-butyl-5-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;1H-Imidazole-4-methanol, 2-butyl-5-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;(2-butyl-5-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-4-yl)methanol;(2-butyl-5-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-4-yl)methanol;(2-Butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol,;(2-Butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol,;(2-butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol;(2-butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol;EN300-747209;EN300-747209;UNII-ILI5UB76JR;UNII-ILI5UB76JR;Losartan Impurity C;Losartan Impurity C;114799-13-2;114799-13-2;LOSARTAN POTASSIUM IMPURITY C [EP IMPURITY];LOSARTAN POTASSIUM IMPURITY C [EP IMPURITY];ILI5UB76JR;ILI5UB76JR;Losartan potassium impurity C [EP];Losartan potassium impurity C [EP];Z3279339299;Z3279339299;Q27280782;Q27280782;(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;[2-butyl-5-chloro-1-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1h-imidazol-4-yl]methanol;[2-butyl-5-chloro-1-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1h-imidazol-4-yl]methanol
EINECS:
分子式：C22H23N6OCL
分子量：422.91062
搜索质检报告(COA)
搜索MSDS
相关产品

已经到最底了
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
© 2010-2025 郑州阿尔法化工有限公司  版权所有，并保留所有权利 豫ICP备19002673号-1 
技术支持：库价化学(KuuJia)
批量搜索 关闭
批处理可以通过CAS号，CAS号，每行一个搜索
...

(1-((2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲基)-2-丁基-5-氯-1H-咪唑-4-基)甲醇
Imp. C (EP): [2-Butyl-5-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-4-yl]methanol;[2-butyl-5-chloro-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-4-methanol;Losartan IMpurity C (Isolosartan);Losartan EP Impurity C (Isolosartan);(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;[2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol;SCHEMBL3121770;SCHEMBL3121770;Losartan Potassium Imp. C (EP); Losartan Imp. C (EP); [2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol; Losartan Potassium Impurity C; Losartan Impurity C;Losartan Potassium Imp. C (EP); Losartan Imp. C (EP); [2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol; Losartan Potassium Impurity C; Losartan Impurity C;1H-Imidazole-4-methanol, 2-butyl-5-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;1H-Imidazole-4-methanol, 2-butyl-5-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;(2-butyl-5-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-4-yl)methanol;(2-butyl-5-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-4-yl)methanol;(2-Butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol,;(2-Butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol,;(2-butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol;(2-butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol;EN300-747209;EN300-747209;UNII-ILI5UB76JR;UNII-ILI5UB76JR;Losartan Impurity C;Losartan Impurity C;114799-13-2;114799-13-2;LOSARTAN POTASSIUM IMPURITY C [EP IMPURITY];LOSARTAN POTASSIUM IMPURITY C [EP IMPURITY];ILI5UB76JR;ILI5UB76JR;Losartan potassium impurity C [EP];Losartan potassium impurity C [EP];Z3279339299;Z3279339299;Q27280782;Q27280782;(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;[2-butyl-5-chloro-1-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1h-imidazol-4-yl]methanol;[2-butyl-5-chloro-1-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1h-imidazol-4-yl]methanol